Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 2022

View Archived Issues

FKBP51 blockade ameliorates cognitive function during obesity

New antibacterials described by the Centre National de la Recherche Scientifique (CNRS)

Bayer discovers soluble guanylate cyclase activators

Cancer Research Technology presents new ALDH1A3 inhibitors

LG Chem identifies new proteasome inhibitors

Scripps Research Institute, Vova Ida Therapeutics patent compounds for treating neurodegeneration

CM-1758 shows cytotoxic effects in models of bladder cancer

PXL-065 demonstrates efficacy in preclinical models of ALD

PP2A inhibition sensitizes cancer cells and inhibits their growth

Biomea's menin inhibitor BMF-219 shows prolonged glycemic control in two rat models of diabetes

Noggin expression has prognostic value in pancreatic cancer

First female-specific Alzheimer's risk gene found

Anti-MASP-2 antibody TST-004 shows promise for MASP-2-dependent diseases in vitro and in vivo

Polysaccharide-protein antigen pneumococcal vaccine effective in type 3 invasive disease model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...